Inscription Capital LLC Has $3.82 Million Stake in Colgate-Palmolive Company $CL

Inscription Capital LLC increased its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 32.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 48,317 shares of the company's stock after purchasing an additional 11,837 shares during the period. Inscription Capital LLC's holdings in Colgate-Palmolive were worth $3,818,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Colgate-Palmolive by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company's stock worth $6,633,570,000 after purchasing an additional 1,026,985 shares during the period. Invesco Ltd. boosted its stake in shares of Colgate-Palmolive by 13.1% during the 3rd quarter. Invesco Ltd. now owns 8,467,993 shares of the company's stock valued at $676,931,000 after buying an additional 978,943 shares during the period. Diamond Hill Capital Management Inc. boosted its stake in shares of Colgate-Palmolive by 46.7% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company's stock valued at $645,719,000 after buying an additional 2,572,796 shares during the period. Ameriprise Financial Inc. boosted its stake in shares of Colgate-Palmolive by 5.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 6,423,764 shares of the company's stock valued at $517,167,000 after buying an additional 314,584 shares during the period. Finally, Amundi boosted its stake in shares of Colgate-Palmolive by 41.6% during the 3rd quarter. Amundi now owns 6,294,445 shares of the company's stock valued at $487,505,000 after buying an additional 1,850,412 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

Analyst Ratings Changes

CL has been the subject of a number of research reports. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "equal weight" rating for the company in a research note on Wednesday, April 8th. Evercore lifted their target price on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the company an "outperform" rating in a research note on Monday, February 2nd. UBS Group decreased their target price on shares of Colgate-Palmolive from $100.00 to $98.00 and set a "buy" rating for the company in a research note on Tuesday, April 7th. Rothschild & Co Redburn set a $100.00 target price on shares of Colgate-Palmolive and gave the company a "buy" rating in a research note on Tuesday, April 21st. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Twelve analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $95.56.

Colgate-Palmolive Stock Up 0.0%

Colgate-Palmolive stock opened at $84.65 on Monday. The company has a market capitalization of $67.92 billion, a P/E ratio of 32.31, a P/E/G ratio of 4.33 and a beta of 0.34. The firm's fifty day simple moving average is $88.79 and its 200-day simple moving average is $83.95. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 EPS. Sell-side analysts forecast that Colgate-Palmolive Company will post 3.85 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be issued a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.52. Colgate-Palmolive's payout ratio is 80.92%.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider John Hazlin sold 20,989 shares of the firm's stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the transaction, the insider owned 17,645 shares in the company, valued at approximately $1,663,041.25. This trade represents a 54.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Panagiotis Tsourapas sold 35,000 shares of the firm's stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the transaction, the chief operating officer owned 10,415 shares in the company, valued at $985,363.15. This represents a 77.07% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 184,683 shares of company stock worth $17,486,693 over the last quarter. Company insiders own 0.43% of the company's stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.